First generic lands on ARTG

Pharmacor has launched an assault on A Menarini's Adenuric, registering four generic brands, Adenubex, Febexic, Uribexo, and Febuxostat Pharmacor, on the ARTG.

It's the first time the treatment - for chronic symptomatic hyperuricaemia in conditions where urate deposition has already occurred in adults with gout - has seen a competitor registered by the TGA.

Sanofi has offered new doses for two products. One is Fluzone High Dose, a stronger version of its trivalent influenza vaccine, presenting 180 mcg instead of 45 mcg.